跳至主要内容
临床试验/IRCT2015061522531N2
IRCT2015061522531N2已完成2 期

Study of the theraputic effect of low dose aspirin on symptoms of chronic rhinosinusitis and nasal polyposis with aspirin sensitivity

Vice chancellor for research, Iran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 64 years(—)
性别
All

入选标准

  • age of 18-65 years; achieving a course of three months of conventional treatment before aspirin challenge; presence of symptoms of chronic rhinosinusitis with nasal polyposis confirmed by CT scan;
  • Exclusion criteria: presence of any serious underlying disease including hemorrhagic; gastrointestinal; rheumatologic; malignant; cardiovascular; renal; hepatic and psychological disorders; history of IgE mediated reactions to aspirin or other non steroidal anti inflammatory drugs; first second expiratory volume of less than 70 percent of predicted at the time of aspirin challenge; pregnancy; nursing; use of topical or systemic beta blockers; warfarin and its derivates; Angiotensin converting enzyme inhibitors; patients with poor cooperation or treatment adherence; patients with carriers with high risk of trauma and accidents;

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Iran University of Medical Sciences

相似试验